Professional Documents
Culture Documents
“European Market”
Group 3
Outline
Company Overview
oSWOT Analysis for WEGO
Target Country Selection Process
oHealth Policy of European
Union
oCountry Comparison
Mode of Entry in European Market
Macro Environment Analysis
Competitive Advantage
oCompetitive Advantage
oCompetitor
Marketing Strategy
Conclusion
SWOT Analysis of WEGO
Strength
Broad product portfolio addressing Weakness
Rising manufacture cost.
diverse customer needs.
Most of the low-end medical
The products are regulated by WHO. products own less profits margin.
The products user friendly.
The products easily replaced by
Growing capacity. competitors.
Opportunity Threat
Expansion of the EU market.
Joint-venture local enterprises.
The competitors actively occupy
The chances of mergers and market share.
acquisitions.
Consolidations to intensify
Health awareness and rising competition.
disposable income of European
The risks of expansive activities.
people.
Health Policy of European Union
First Objective : Improve Citizens Health Security
Second Objective: Promote Health And Reduce Health
Inequalities
Third Objective : Generate And Disseminate Health
Information And Knowledge
The programme is
managed by The
Commission
and Public
Health
Executive
Agency (PHEA)
Data Source:
Mode of Entry – Joint Venture
“Jointventure is an equity mode of market entry. It entails
establishing a firm that is jointly owned by two or more
independent firms” (Peng,2010)
Advantages:
ALOKA
Established in 1960, is the
longest operating and pioneer
ultrasound company in the world
with international head quarters
in Japan, European Headquarters
in Switzerland.
v
Why Aloka?
vLocal sales and service offices in almost all 27 EU countries
vIn depth market knowledge
vCredibility and Reputation
v
BACK-UP PLAN: Exporting through
Sales Subsidiaries to The Netherlands
vSea network link from China to The
Netherland: reduction in
transportation cost
vSafe mode of market entry
vMore cargo
Macro Environment Analysis*
Market Knowledge
Collaboration
Joint-Venture strategy Experienced
Becton and Dickinson or BD
Analysis
Potential Market in Head Quarter in France and focusing
Europe in Western Europe
syringes
qMedicos, paramedical staff and nurses along with patients are
Question no.5